Ringkasan AI
We reviewed 6 live results for abraxane and narrowed them down to the 3 options that look most worth comparing first.
The strongest themes across this short list are Chemotherapy and Oncology.
We reviewed 6 live results for abraxane and narrowed them down to the 3 options that look most worth comparing first.
The strongest themes across this short list are Chemotherapy and Oncology.
Sumber: Bristol Myers Squibb (Singapore)
Deskripsi
Abraxane is a registered chemotherapy medication consisting of albumin-bound paclitaxel (nab-paclitaxel) for intravenous injection. This nanoparticle technology allows for more effective delivery of paclitaxel to cancer cells. It is primarily used in oncology for treating metastatic breast cancer, non-small cell lung cancer (NSCLC), and pancreatic cancer. In Singapore, it is listed on the National Drug Formulary and the MediShield Life Outpatient Cancer Drug List for specific subsidised indications.
Paling cocok untuk
metastatic breast cancer patients, pancreatic cancer treatment, non-small cell lung cancer and oncology patients in Singapore
Penilaian
Sumber: Bristol-Myers Squibb (BMS) Malaysia
Deskripsi
A specialized formulation of paclitaxel protein-bound particles for injectable suspension. It is registered in Malaysia for the treatment of metastatic breast cancer and pancreatic adenocarcinoma.
Paling cocok untuk
metastatic breast cancer, pancreatic adenocarcinoma and albumin-bound chemotherapy
Penilaian
Sumber: Tan Tock Seng Hospital (TTSH) Pharmacy
Deskripsi
Administration of Abraxane via intravenous injection within a clinical hospital setting. Services include specialist consultation, pharmacy supply, and patient medication guides for breast, pancreas, and lung cancer treatments. As a public institution, TTSH supports subsidised healthcare through the National Drug Formulary.
Paling cocok untuk
subsidised healthcare seekers, public hospital patients and oncology medication guidance
Penilaian
| Bandingkan | Abraxane (nab-paclitaxel) 100mg/vial | Abraxane | Nab-paclitaxel (Abraxane) Administration |
|---|---|---|---|
| Sumber | Bristol Myers Squibb (Singapore) | Bristol-Myers Squibb (BMS) Malaysia | Tan Tock Seng Hospital (TTSH) Pharmacy |
| Deskripsi | Abraxane is a registered chemotherapy medication consisting of albumin-bound paclitaxel (nab-paclitaxel) for intravenous injection. This nanoparticle technology allows for more effective delivery of paclitaxel to cancer cells. It is primarily used in oncology for treating metastatic breast cancer, non-small cell lung cancer (NSCLC), and pancreatic cancer. In Singapore, it is listed on the National Drug Formulary and the MediShield Life Outpatient Cancer Drug List for specific subsidised indications. | A specialized formulation of paclitaxel protein-bound particles for injectable suspension. It is registered in Malaysia for the treatment of metastatic breast cancer and pancreatic adenocarcinoma. | Administration of Abraxane via intravenous injection within a clinical hospital setting. Services include specialist consultation, pharmacy supply, and patient medication guides for breast, pancreas, and lung cancer treatments. As a public institution, TTSH supports subsidised healthcare through the National Drug Formulary. |
| Paling cocok untuk | metastatic breast cancer patients, pancreatic cancer treatment, non-small cell lung cancer and oncology patients in Singapore | metastatic breast cancer, pancreatic adenocarcinoma and albumin-bound chemotherapy | subsidised healthcare seekers, public hospital patients and oncology medication guidance |
| Tag | |||
| Aksi | Lihat detail | Lihat detail | Lihat detail |
| Penilaian |
Jika Anda ingin memulai dari opsi yang paling seimbang, saya merekomendasikan:
"Abraxane (nab-paclitaxel) 100mg/vial from Bristol Myers Squibb (Singapore)."
Saya memilih ini karena This is the official therapeutic product registered in Singapore, essential for oncology patients requiring nanoparticle albumin-bound paclitaxel chemotherapy.